Kura Oncology Inc (NAS:KURA)
$ 8.86 -0.08 (-0.89%) Market Cap: 688.99 Mil Enterprise Value: 250.32 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 29/100

Kura Oncology Inc at JMP Securities Life Sciences Conference Transcript

Jun 16, 2022 / 06:30PM GMT
Release Date Price: $13.26 (-5.49%)
Ren Benjamin
JMP Securities LLC - Analyst

Good afternoon, everyone, and welcome. It's my pleasure to introduce Kura Oncology, a leader in the menin and transferase inhibitor space -- farnesyl transferase inhibitor space. Presenting for the company is Troy Wilson. Welcome, Troy, remotely.

But you know how I'd like to do these talks. I'd love for you to kind of level set the audience first because I never know who is listening in for the first time. Can you tell us a little bit about Kura Oncology? And then we can dig into some of the details.

Troy Wilson
Kura Oncology, Inc. - President & CEO

Sure, Ren. Good afternoon and thank you to you and JMP for the invitation to the conference. I'm sorry I couldn't be there in person.

For the audience's benefit, I am recovering from COVID and thought it best to keep everybody safe. But you were very kind to make arrangements to have me join you remotely.

As far as Kura, as you laid out nicely, Ren, we are in the targeted oncology space. Three principal pillars to the business: our menin

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot